Highly Potent RANTES Analogues either Prevent CCR5-Using Human Immunodeficiency Virus Type 1 Infection In Vivo or Rapidly Select for CXCR4-Using Variants
暂无分享,去创建一个
Pascal Poignard | Donald E. Mosier | Jill Wilken | L. Picard | P. Poignard | R. Offord | D. Mosier | R. Gulizia | Robin E. Offord | G. Picchio | Rebecca Sabbe | D. A. Thompson | J. Wilken | Gastón R. Picchio | Richard J. Gulizia | Rebecca Sabbe | Laurent Picard | Darren A. Thompson | R. Sabbe
[1] Robin A. Weiss,et al. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain , 1986, Cell.
[2] D. Mosier. Human immunodeficiency virus infection of human cells transplanted to severe combined immunodeficient mice. , 1996, Advances in immunology.
[3] D. Ho,et al. Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry , 1997, Journal of virology.
[4] M. Emerman,et al. Activation of a beta-galactosidase recombinant provirus: application to titration of human immunodeficiency virus (HIV) and HIV-infected cells , 1990, Journal of virology.
[5] D. Ho,et al. Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals , 1993, Journal of virology.
[6] D. Ho,et al. In Vivo Distribution of the Human Immunodeficiency Virus/Simian Immunodeficiency Virus Coreceptors: CXCR4, CCR3, and CCR5 , 1998, Journal of Virology.
[7] W. Gong,et al. Chemically Synthesized SDF-1α Analogue, N33A, Is a Potent Chemotactic Agent for CXCR4/Fusin/LESTR-expressing Human Leukocytes* , 1997, The Journal of Biological Chemistry.
[8] R. Doms,et al. A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains , 1996, Journal of virology.
[9] Ying Sun,et al. The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates , 1996, Cell.
[10] B. Korber,et al. A new classification for HIV-1 , 1998, Nature.
[11] J. Goudsmit,et al. ASSOCIATION BETWEEN BIOLOGICAL PROPERTIES OF HUMAN IMMUNODEFICIENCY VIRUS VARIANTS AND RISK FOR AIDS AND AIDS MORTALITY , 1989, The Lancet.
[12] Paul E. Kennedy,et al. HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor , 1996, Science.
[13] B. Margolin,et al. Patterns of amino acid variability in NSI-like and SI-like V3 sequences and a linked change in the CD4-binding domain of the HIV-1 Env protein. , 1997, Virology.
[14] Ying Sun,et al. Two Orphan Seven-Transmembrane Segment Receptors Which Are Expressed in CD4-positive Cells Support Simian Immunodeficiency Virus Infection , 1997, The Journal of experimental medicine.
[15] C. Barbas,et al. Protection against HIV‐1 infection in hu‐PBL-SCID mice by passive immunization with a neutralizing human monoclonal antibody against the gp120 CD4‐binding site , 1995, AIDS.
[16] Besch Cl,et al. Compliance in clinical trials. , 1995 .
[17] M. Baggiolini,et al. HIV blocked by chemokine antagonist , 1996, Nature.
[18] C. Broder,et al. Cell type-specific fusion cofactors determine human immunodeficiency virus type 1 tropism for T-cell lines versus primary macrophages , 1996, Journal of virology.
[19] Richard A Koup,et al. Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection , 1996, Cell.
[20] R. Swanstrom,et al. Evolutionary variants of the human immunodeficiency virus type 1 V3 region characterized by using a heteroduplex tracking assay , 1997, Journal of virology.
[21] T. Muir,et al. Synthesis of proteins by native chemical ligation. , 1994, Science.
[22] B. Chesebro,et al. The Cell Tropism of Human Immunodeficiency Virus Type 1 Determines the Kinetics of Plasma Viremia in SCID Mice Reconstituted with Human Peripheral Blood Leukocytes , 1998, Journal of Virology.
[23] A. Garzino-Demo,et al. The V3 domain of the HIV–1 gp120 envelope glycoprotein is critical for chemokine–mediated blockade of infection , 1996, Nature Medicine.
[24] M. Montjovent,et al. Extension of Recombinant Human RANTES by the Retention of the Initiating Methionine Produces a Potent Antagonist (*) , 1996, The Journal of Biological Chemistry.
[25] D. Richman,et al. The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression. , 1994, The Journal of infectious diseases.
[26] D E Mosier,et al. Human immunodeficiency virus infection of human-PBL-SCID mice. , 1991, Science.
[27] Miriam K. Konkel,et al. The Orphan Seven-Transmembrane Receptor Apj Supports the Entry of Primary T-Cell-Line-Tropic and Dualtropic Human Immunodeficiency Virus Type 1 , 1998, Journal of Virology.
[28] Marc Parmentier,et al. A Dual-Tropic Primary HIV-1 Isolate That Uses Fusin and the β-Chemokine Receptors CKR-5, CKR-3, and CKR-2b as Fusion Cofactors , 1996, Cell.
[29] R. Connor,et al. Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected Individuals , 1997, The Journal of experimental medicine.
[30] C. Combadière,et al. Cloning and functional expression of CC CKR5, a human monocyte CC chemokine receptor selective for MIP‐1α, MIP‐1β, and RANTES , 1996, Journal of leukocyte biology.
[31] D E Mosier,et al. Rapid loss of CD4+ T cells in human-PBL-SCID mice by noncytopathic HIV isolates. , 1993, Science.
[32] M. Mack,et al. Aminooxypentane-RANTES Induces CCR5 Internalization but Inhibits Recycling: A Novel Inhibitory Mechanism of HIV Infectivity , 1998, The Journal of experimental medicine.
[33] T. Schwartz,et al. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. , 1997, Science.
[34] J. McCune,et al. Antiviral efficacy in vivo of the anti-human immunodeficiency virus bicyclam SDZ SID 791 (JM 3100), an inhibitor of infectious cell entry , 1996, Antimicrobial agents and chemotherapy.
[35] E. Berger. HIV entry and tropism: the chemokine receptor connection. , 1997, AIDS.
[36] C. Blondin,et al. Plasma levels of monocyte chemoattractant protein-1 but not those of macrophage inhibitory protein-1alpha and RANTES correlate with virus load in human immunodeficiency virus infection. , 1997, The Journal of infectious diseases.
[37] K. Peden,et al. A new SIV co-receptor, STRL33 , 1997, Nature.
[38] Stephen C. Peiper,et al. Identification of a major co-receptor for primary isolates of HIV-1 , 1996, Nature.
[39] B. Chesebro,et al. Mapping of independent V3 envelope determinants of human immunodeficiency virus type 1 macrophage tropism and syncytium formation in lymphocytes , 1996, Journal of virology.
[40] B. Chesebro,et al. Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop , 1997, Journal of virology.
[41] C. Barbas,et al. Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1 , 1997, Nature Medicine.
[42] Berger Ea. HIV entry and tropism: the chemokine receptor connection. , 1997 .